2023

1. Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension

   American Journal of Respiratory Cell and Molecular Biology, Vol. 69, Núm. 2, pp. 147-158

2. The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit

   Biomedicine and Pharmacotherapy, Vol. 164